GlassScriptPhysician profile
Karen E Chiu
NPI 1851491591
$1,163.75
in general payments reported to CMS, 2019-2025
16 companies · $205 in 2025
The $205 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $185 · 2022: $24.90 · 2023: $166 · 2024: $583 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $954.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $954.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $208.11 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $158.06 | 2024 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $102.79 | 2023-2025 | Lifevest |
| Medtronic, INC. | $99.96 | 2023 | Hawkone |
| Glaxosmithkline, LLC. | $95.99 | 2021 | |
| Abbvie INC. | $83.93 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.98 | 2021-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $59.72 | 2024-2025 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $59.47 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $55.19 | 2024 | |
| Novo Nordisk INC | $53.77 | 2021-2025 | Ozempic |
| Dexcom, INC. | $39.51 | 2021-2023 | Dexcom G6 Transmitter |
| Amgen INC. | $24.90 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $21.86 | 2025 | Camzyos |
| Lilly USA, LLC | $21.46 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $19.05 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Chiu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.